18-30996796-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001941.5(DSC3):c.2488G>A(p.Gly830Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,613,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001941.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC3 | NM_001941.5 | c.2488G>A | p.Gly830Ser | missense_variant | 15/16 | ENST00000360428.9 | NP_001932.2 | |
DSC3 | NM_024423.4 | c.2488G>A | p.Gly830Ser | missense_variant | 15/17 | NP_077741.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC3 | ENST00000360428.9 | c.2488G>A | p.Gly830Ser | missense_variant | 15/16 | 1 | NM_001941.5 | ENSP00000353608.4 | ||
DSC3 | ENST00000434452.5 | c.2488G>A | p.Gly830Ser | missense_variant | 15/17 | 5 | ENSP00000392068.1 | |||
DSC3 | ENST00000584980.1 | c.610G>A | p.Gly204Ser | missense_variant | 4/6 | 5 | ENSP00000464283.1 |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 156AN: 151962Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000311 AC: 78AN: 250704Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135574
GnomAD4 exome AF: 0.0000965 AC: 141AN: 1461412Hom.: 0 Cov.: 31 AF XY: 0.0000825 AC XY: 60AN XY: 727014
GnomAD4 genome AF: 0.00103 AC: 156AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000928 AC XY: 69AN XY: 74344
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The DSC3 p.Gly830Ser variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs142851621) and Cosmic (FATHMM prediction of pathogenic; score=0.74). The variant was also identified in control databases in 105 of 282074 chromosomes at a frequency of 0.000372 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 96 of 24946 chromosomes (freq: 0.003848), Other in 1 of 7214 chromosomes (freq: 0.000139), Latino in 3 of 35412 chromosomes (freq: 0.000085) and European (non-Finnish) in 5 of 128484 chromosomes (freq: 0.000039); it was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) or South Asian populations. The p.Gly830 residue is not conserved in mammals and four out of five computational analyses (SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 3 of 4 in silico or computational prediction software programs (SpliceSiteFinder, NNSPLICE, GeneSplicer) do not predict a difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 16, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at